Evaluation of Serum Phenyl Lactate as a diagnostic test of Non Alcoholic Fatty Liver Disease in Egyptian Patients
Ahmed Elsayed Mohamed Badawy;
Abstract
Nonalcoholic fatty liver disease (NAFLD) is currently recognized as one of the most prevalent etiologies of chronic liver disease worldwide. NAFLD is estimated to afflict approximately 80-100 million adults in the United
States. NAFLD is broadly classified into nonalcoholic fatty liver, the non-progressive form of NAFLD, and nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD. Patients with NASH have a higher risk of progression to cirrhosis and hepatocellular carcinoma and are at an increased risk of liver-related morbidity and mortality.
States. NAFLD is broadly classified into nonalcoholic fatty liver, the non-progressive form of NAFLD, and nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD. Patients with NASH have a higher risk of progression to cirrhosis and hepatocellular carcinoma and are at an increased risk of liver-related morbidity and mortality.
Other data
| Title | Evaluation of Serum Phenyl Lactate as a diagnostic test of Non Alcoholic Fatty Liver Disease in Egyptian Patients | Other Titles | تقييم الفينيل لاكتات في الدم كاختبار تشخيصي لمرض الكبد الدهني غير الكحولي في المرضى المصرييين | Authors | Ahmed Elsayed Mohamed Badawy | Issue Date | 2019 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.